Citation: Mj. Janse et Jmt. De Bakker, Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable cardioverter-defibrillators, EUR H J SUP, 3(L), 2001, pp. L15-L20
Citation: Al. Wit et Mj. Janse, Reperfusion arrhythmias and sudden cardiac death - A century of progress toward an understanding of the mechanisms, CIRCUL RES, 89(9), 2001, pp. 741-743
Authors:
Carmeliet, E
Fozzard, HA
Hiraoka, M
Janse, MJ
Ogawa, S
Roden, DM
Rosen, MR
Rudy, Y
Schwartz, PJ
Matteo, PS
Antzelevitch, C
Boyden, PA
Catterall, WA
Fishman, GI
George, AL
Izumo, S
Jalife, J
January, CT
Kleber, AG
Marban, E
Marks, AR
Spooner, PM
Waldo, AL
Weiss, JM
Zipes, DLP
Citation: E. Carmeliet et al., New approaches to antiarrhythmic therapy, part I - Emerging therapeutic applications of the cell biology of cardiac arrhythmias, CIRCULATION, 104(23), 2001, pp. 2865-2873
Authors:
Coronel, R
Wilms-Schopman, FJG
De Groot, JR
Janse, MJ
Van Capelle, FJL
De Bakker, JMT
Citation: R. Coronel et al., Laplacian electrograms and the interpretation of complex ventricular activation patterns during ventricular fibrillation, J CARD ELEC, 11(10), 2000, pp. 1119-1128
Authors:
Malik, M
Camm, AJ
Janse, MJ
Julian, DG
Frangin, GA
Schwartz, PJ
Citation: M. Malik et al., Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone - A substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial), J AM COL C, 35(5), 2000, pp. 1263-1275
Authors:
Haverkamp, W
Breithardt, G
Camm, AJ
Janse, MJ
Rosen, MR
Antzelevitch, C
Escande, D
Franz, M
Malik, M
Moss, A
Shah, R
Citation: W. Haverkamp et al., The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications - Report on a Policy Conferenceof the European Society of cardiology, EUR HEART J, 21(15), 2000, pp. 1216-1231
Authors:
Opthof, T
Coronel, R
Rademaker, HME
Vermeulen, JT
Wilms-Schopman, FJG
Janse, MJ
Citation: T. Opthof et al., Changes in sinus node function in a rabbit model of heart failure with ventricular arrhythmias and sudden death, CIRCULATION, 101(25), 2000, pp. 2975-2980
Authors:
Haverkamp, W
Breithardt, G
Camm, AJ
Janse, MJ
Rosen, MR
Antzelevitch, C
Escande, D
Franz, M
Malik, M
Moss, A
Shah, R
Citation: W. Haverkamp et al., The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications Report on a Policy Conferenceof the European Society of Cardiology, CARDIO RES, 47(2), 2000, pp. 219-233
Citation: Mj. Janse et al., Is the atrium involved in AV nodal reentry?, ATRIAL-AV NODAL ELECTROPHYSIOLOGY: A VIEW FROM THE MILLENNIUM, 2000, pp. 175-182
Authors:
de Bakker, JMT
Loh, P
Hocini, M
Thibault, B
Janse, MJ
Citation: Jmt. De Bakker et al., Double component action potentials in the posterior approach to the atrioventricular node: Do they reflect activation delay in the slow pathway?, J AM COL C, 34(2), 1999, pp. 570-577
Authors:
Loh, P
de Bakker, JMT
Hocini, M
Thibault, B
Hauer, RNW
Janse, MJ
Citation: P. Loh et al., Reentrant pathway during ventricular echoes is confined to the atrioventricular node - High-resolution mapping and dissection of the triangle of Kochin isolated, perfused canine hearts, CIRCULATION, 100(12), 1999, pp. 1346-1353